5 "pancreas cancer" clinical trials found.
-
A phase II study of nivolumab cabiralizumab and stereotactic body radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer
If you have been diagnosed with pancreatic cancer, you may qualify for this Phase II study. The main goal of this study is to determine ...
Phase
Interventional
Match Level: Exact
-
Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates
The goal of this phase II study is to obtain safety and preliminary efficacy for and estimate the R0 resection rate in patients with ...
Phase
Interventional
Match Level: Exact
-
A Phase 3 Randomized Double-Blind Placebo-Controlled Multicenter Study of PEGPH20 in Combination With nab-Paclitaxel and Gemcitabine in Subjects with Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma
If you have been diagnosed with pancreatic cancer, you may qualify to participate in a study evaluating the clinical benefits of an investigational drug, ...
Phase
Interventional
Match Level: Medium
-
CA025-006 A Phase 2 Study of Cabiralizumab (BMS-986227 FPA008) Administered in Combination with Nivolumab (BMS-936558) with and without Chemotherapy in Patients with Advanced Pancreatic Cancer relating to BMS Compounds: BMS-986227 FPA008
If you have been diagnosed with pancreatic cancer which has progressed during or after at least one line of systemic chemotherapy, you may qualify for ...
Phase
Interventional
Match Level: Medium
-
A Phase I/IIa Study of BMS-986205 Administered in Combination with Nivolumab (BMS-935558 anti-PD-1 Monoclonal Antibody) in Advanced Malignant Tumors
If you have been diagnosed with advanced(metastatic (spread to another area of the body) and/or unresectable (cannot be removed from the body)) malignant tumors, including ...
Phase
Interventional
Match Level: Low
Showing - of trials
